当前位置: 首页 > 详情页

The Effect of Statins on Erectile Dysfunction: A Systematic Review and Meta-Analysis

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Tian Tan Hosp, Dept Urol, Beijing 100050, Peoples R China; [2]Capital Med Univ, Beijing Tian Tan Hosp, Dept Urol, 6 Tiantan Xi Li, Beijing 100050, Peoples R China
出处:
ISSN:

关键词: Statins Erectile Dysfunction Hypercholesterolemia Meta-Analysis Randomized Controlled Trial

摘要:
Introduction It is not known if statins will improve symptoms in patients with established erectile dysfunction (ED). Aim We carried out a systematic review and meta-analysis to assess the effect of statins on ED. Methods A literature review was performed to identify all published randomized double-blind, placebo-controlled trials of statins for the treatment of ED. The search included the following databases: MEDLINE, Embase, and the Cochrane Controlled Trials Register. The reference lists of the retrieved studies were also investigated. A systematic review and meta-analysis were conducted. Main Outcome Measures Six publications involving a total of 462 patients were used in the analysis, including three randomized controlled trials (RCTs) that compared statins with placebo and three RCTs that compared statins plus sildenafil with placebo plus sildenafil. Results For the comparison of statins (+/- sildenafil) with placebo (+/- sildenafil), the mean International Index of Erectile Function (IIEF-5) (the standardized mean difference [SMD]=3.23, 95% confidence interval [CI]=-1.65 to 4.80, P<0.0001) indicated that statins (+/- sildenafil) showed statistically significantly greater improvements in the mean IIEF-5 compared with placebo (+/- sildenafil). For the comparison of statins with placebo, the mean IIEF-5 (SMD=2.13, 95% CI=-1.46 to 5.73, P=0.24) indicated that there was no significant difference in erectile function between the statins and placebo. For the comparison of statins plus sildenafil with placebo plus sildenafil, the mean IIEF-5 (SMD=3.60, 95% CI=2.64 to 4.56, P<0.00001), the IIEF domain (SMD=4.88, 95%CI=3.01 to 6.74, P<0.00001), and the global efficacy question (odds ratio=6.44, 95% CI=2.92 to 14.23, P<0.00001) showed that compared with placebo plus sildenafil, statins plus sildenafil clearly improved erectile function. Conclusions This meta-analysis indicates that statins (+/- sildenafil) may improve ED compared with placebo (+/- sildenafil). Cui Y, Zong H, Yan H, and Zhang Y. The effect of statins on erectile dysfunction: A systematic review and meta-analysis. J Sex Med 2014;11:1367-1375.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 2 区 医学
小类 | 2 区 泌尿学与肾脏学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 泌尿学与肾脏学
JCR分区:
出版当年[2012]版:
Q1 UROLOGY & NEPHROLOGY
最新[2023]版:
Q1 UROLOGY & NEPHROLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Tian Tan Hosp, Dept Urol, Beijing 100050, Peoples R China;
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Tian Tan Hosp, Dept Urol, Beijing 100050, Peoples R China; [2]Capital Med Univ, Beijing Tian Tan Hosp, Dept Urol, 6 Tiantan Xi Li, Beijing 100050, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17005 今日访问量:0 总访问量:906 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院